Skip to main content
. 2021 Jan 20;11:583485. doi: 10.3389/fneur.2020.583485

Table 3.

Incidence (per 1000 PYs) and depression risk for insomnia patients with and without CHMs in the stratification of sex and age.

Variables Non-CHMs users CHMs users Crude HR (95% CI) Adjusted HR (95% CI)
Case PYs Incidence Case PYs Incidence
Female
≤50 2,949 52986.41 55.66 1,158 64092.24 18.07 0.32 (0.30–0.35) 0.32 (0.31–0.35)*
>50 2,026 60012.79 33.76 1,106 59922.36 18.46 0.55 (0.49–0.57) 0.53 (0.50–0.57)*
All 4,975 112999.2 44.03 2,264 124014.6 18.26 0.41 (0.42–0.46) 0.41 (0.38–0.43)Ω
Male
≤50 1,296 39882.51 32.50 590 39102.37 15.09 0.46 (0.41–0.50) 0.45 (0.41–0.50)*
>50 717 31207.56 22.98 474 29920.76 15.84 0.69 (0.59–0.75) 0.66 (0.59–0.74)*
All 2,013 71090.07 28.32 1,064 69023.13 15.42 0.54 (0.49–0.57) 0.53 (0.49–0.57)Ω
*

Model adjusted for urbanization level, monthly income, medication usage and CCI score.

Ω

Model adjusted for age, urbanization level, monthly income, medication usage and CCI score.